Taste-masking composition of bitter pharmaceutical agents
October 24, 2014. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3627885 N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor 11-Methyl-11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl-7,1 3,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one and derivatives thereof Effervescent composition and method of making same Medicament adsorbates of analgesics with complex magnesium aluminum silicate and their preparation Taste-masked pharmaceutical compositions Patent #: 4800087 InventorsApplicationNo. 328977 filed on 10/24/1994US Classes:424/441, Chewable tablet or wafer424/439, Food or edible as carrier for pharmaceutical514/974CONTAINING DESIGNATED INGREDIENT TO REDUCE NOXIOUS EFFECTS OF ACTIVE INGREDIENT (E.G., TASTE MASKING, ODOR REDUCING, ETC.)ExaminersPrimary: Webman, Edward J.Attorney, Agent or FirmForeign Patent References
International ClassesA61K 009/20A61K 047/02 AbstractA pharmaceutical composition having reduced bitterness consisting of a bitter pharmaceutical agent, a taste-masking component and a pharmaceutically acceptable carrier. The taste-masking component is an alkaline earth oxide, an alkaline earth hydroxide or an alkaline hydroxide and does not interfere with the activity of the pharmaceutical agent.Other References
Field of SearchContains proteins or derivative or polysaccharides or derivativeContains solid synthetic resin Food or edible as carrier for pharmaceutical Chewable tablet or wafer Discrete particles in supporting matrix Where particles are granulated Oxide or hydroxide Magnesium hydroxide or oxide CONTAINING DESIGNATED INGREDIENT TO REDUCE NOXIOUS EFFECTS OF ACTIVE INGREDIENT (E.G., TASTE MASKING, ODOR REDUCING, ETC.) | |
